Globus Medical Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
13.7%projected annual EPS growth
Analyst Coverage
13analysts covering
FY Revenue (est.)
$3.2Bnext fiscal year
FY EPS (est.)
$4.98next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 5 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Worldwide Net Sales Growth Quarterly2,700.0%Target: $3.18 billion to $3.22 billion
Base Business Net Sales Growth (excluding Nevro) Quarterly1,320.0%
Adjusted Gross Profit Margin Quarterly6,920.0%
Adjusted EBITDA Margin Quarterly3,230.0%
Watch Items
- Nevro Integration and Sequential Revenue Performance
- Excelsius Surgical Robotics Commercial Model Shift
- U.S. Spine Market Share Gains
Research as of 2 Sep 2026